Bridging the Regulatory Divide: A Dual-Pathway Framework Using SRA Approvals and AI Evaluation to Ensure Drug Quality in Developing Countries
<b>Background:</b> Developing countries face significant challenges in accessing high-quality pharmaceutical products due to resource constraints, limited regulatory capacity, and market dynamics that often prioritize cost over quality. This review addresses the critical gap in regulator...
Saved in:
| Main Author: | Sarfaraz K. Niazi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/7/1024 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LncRNA SRA gene polymorphisms and risk of gynecological pathology development among Ukrainian women with proliferative type of benign breast disease without atypia
by: I. M. Lukavenko, et al.
Published: (2021-10-01) -
RETRACTED: Assessing Multidimensional Energy Poverty and Its Economic Impact on N11 Countries: Mediating Role of Energy Efficiency
by: Manh Pham Hong, et al.
Published: (2022-08-01) -
Proposal of International Council for Harmonization (ICH) Guideline for the Approval of Biosimilars
by: Sarfaraz K. Niazi, et al.
Published: (2023-12-01) -
Advancements in regulatory agility, regional collaboration, and digital transformation: insights from the Asia Partnership Conference of Pharmaceutical Associations (APAC)
by: Sannie Siaw Foong Chong, et al.
Published: (2024-12-01) -
Regulatory Perspectives for AI/ML Implementation in Pharmaceutical GMP Environments
by: Sarfaraz K. Niazi
Published: (2025-06-01)